Thelansis

Bazex-Dupre-Christol Syndrome Market Outlook Thelansis’s “Bazex-Dupre-Christol Syndrome Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Bazex-Dupre-Christol Syndrome treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the greatest impact on t...

Bazex-Dupre-Christol Syndrome Market Outlook Thelansis’s “Bazex-Dupre-Christol Syndrome Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Bazex-Dupre-Christol Syndrome treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Bazex-Dupre-Christol Syndrome Overview Bazex-Dupre-Christol Syndrome (BDC) is characterized clinically by multiple basal cell carcinomas of the face that primarily occur in the second and third decade of life, follicular atrophoderma primarily of the dorsum sides of the hands and feet, and generalized hypotrichosis; occasionally with pili torti and trichorrhexis nodosa. Milia, hypohidrosis, and calcifying epithelial ...

  Bazex-Dupre-Christol (BDC) syndrome is characterized clinically by multiple basal cell carcinomas of the face that primarily occur in the second and third decade of life, follicular atrophoderma primarily of the dorsum sides of the hands and feet, and generalized hypotrichosis; occasionally with pili torti and trichorrhexis nodosa. Milia, hypohidrosis, and calcifying epithelial tumors are all symptoms of BDC. Four members of one family with BDC syndrome, a mother and her three daughters, were reported in this study. The major clinical features of BDC were very typical in the mother and one of the daughters, whereas the other two daughters only had follicular atrophoderma, milia, and hypotrichosis. Bazex Dupre Christol Syndrome is a hereditary multiple basal cell carcinoma (BCC) syndrome whose inheritance pattern is X-linked dominant, implying that all daughters of affected mothers should have this disease. Bazex-Dupre-Christol (BDC) incidence ranges from 1 to 1.5 cases per millio...